Payment & Shipping Terms:
|Application:||Anti Liver Canver||COA:||Available|
pharmaceutical active ingredients,
active pharma ingredients
Liver Cancer Treatment Miriplatin Active Pharmaceutical Ingredient CAS 141977-79-9
Miriplatin was approved for lipiodolization for the treatment of hepatocellular carcinoma in 2009. It is a lipophilic platinum complex containing myristates as leaving groups, and can be easily suspended in ethyl esters of iodized fatty acids obtained from poppy seed oil.
Miriplatin suspension was active and was retained selectively in rat hepatic tumors after intra-hepatic arterial administration with reduced toxicities in normal livers and the whole body. In this review, we summarize the characteristic formulation, preclinical studies, and clinical studies of miriplatin.
|Therapeutic Category||Antineoplastic agent|
|Chemical Name||(SP-4-2)-[(1R,2R)-cyclohexane-1,2-diamine-N,N')bis(tetradecanoato-Oplatinum (WHO)|
|Foreign Names||Miriplatinum (Latin)
SM 11355 (IS)
Miriplatin Hydrate (OS: JAN)
1. Are you a manufacturer ?
Yes, We manufacture bulk products in our factory located in Jiayu, Hubei, and produce small quantity and customer synthesis products in our lab located in Wuhan. But we also do some trading business
2. How to confirm the product quality before placing orders ?
3. How to make order & payment ?
4. How to pack and storage ?
25kg/Fiber drum with double PE bags inside.
5. How to ship and delivery ?
For small order, please expect 5-7 days by DHL,UPS,TNT, FEDEX, EMS.
For mass order, please allow 5-8 days by Air, 20-35 days by Sea.
6. Our return service policy
We offer an unconditional,full money back guarantee. if you are not 100% satisfied with our products,return all goods back to us within 60 day and we will fully refund your money. No questions asked.
Contact Person: Ms. du
Tel: 86 13277095342